Ixaltis
Ixaltis is a pharmaceutical company that develops therapeutics to treat genitourinary disorders with unsatisfied medical needs.
Based based in European Union (EU), Europe, Middle East, and Africa (EMEA), Ixaltis works in biopharma, biotechnology, health care, medical, medical device, pharmaceutical, therapeutics, founded in 2012.
As a business in biopharma, biotechnology, health care, medical, medical device, pharmaceutical, therapeutics, Ixaltis is listed here with the public details available about it.
The business is associated with European Union (EU), Europe, Middle East, and Africa (EMEA).
The company is listed at the Series_Unknown stage of development.
Its team size is recorded as c_00011_00050 employees.
It has disclosed roughly $8M in funding.
| Sector | Biopharma, Biotechnology, Health Care, Medical, Medical Device, Pharmaceutical, Therapeutics |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2012 |
| Employees | c_00011_00050 |
| Stage | series_unknown |
| Total funding | $8,000,000 |
Website: www.ixaltis.com
Browse related
Create a free account